Diabete : Bloedglucosebepaling, Vaag A., Pedersen K.D., Lauritzen M. Hildebrandt P., Beck Nielsen H. : Intramuscular versus subcutaneous injection of unmodified Insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. (BD Medical/Diabetes Care)
 


suikerziekte



  • glucose

  • bloedglucosebepaling

  • diabetes





  • glucose, bloedglucosebepaling, diabetes

      
    Home > Sitemap > Informatie centrum > Medische referenties : Bloedglucosebepaling > Vaag A., Pedersen K.D., Lauritzen M. Hildebrandt P., Beck Nielsen H. : Intramuscular versus subcutaneous injection of unmodified Insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Vaag A., Pedersen K.D., Lauritzen M. Hildebrandt P., Beck Nielsen H. : Intramuscular versus subcutaneous injection of unmodified Insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.  Back
    Hvidore Hospital, Copenhagen, Denmark.

    Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Using the perpendicular injection technique lean diabetic patients may often inject insulin intramuscularly (IM). Guided by ultrasound measurements of the subcutaneous (SC) thickness of the thigh, the aim of the present study was to re-evaluate the absorption kinetics of unmodified insulin from IM and SC injection sites and to evaluate the consequences of IM injection of unmodified insulin for blood glucose control in Type 1 diabetic patients. T50% values (time until 50% of the injected insulin is absorbed from the injection site) of SC injected, radioactively labelled, human unmodified insulin (125I-Actrapid) were 338 +/- 13 (+/- SE) min, 289 +/- 27 min, and 287 +/- 27 min during rest, light physical activity, and strenuous exercise, respectively. Intramuscularly injected unmodified insulin was absorbed faster, T50% 232 +/- 20 min, 113 +/- 13 min, and 112 +/- 5 min during the same levels of physical activity in the same order. When unmodified insulin (Actrapid) was given IM 30 min before breakfast, lunch, and dinner together with intermediate-acting insulin (Protaphane) SC at 2200 h, a more physiological profile of plasma free insulin and a more stable blood glucose profile was obtained than with SC administration into the thigh. The coefficient of variation of blood glucose concentration during the study (3 days each route) was lower with IM than with SC injection of unmodified insulin (33 +/- 4 vs 43 +/- 3%, p less than 0.01). No difference in frequency of hypoglycaemic attacks was found and patients claimed that IM injection was no more painful than SC injection. These data suggest that IM injection of soluble insulin into the thigh is beneficial.

    If you would like to obtain the full article, please contact the publisher : Blackwell Science Ltd at the following e-mail address:
    journals.cs@blacksci.co.uk or phone number:
    +44 1865 206206.

     
         

    Diabetes in het dagelijkse leven, Ziekte

    Bloedglucosebepaling, McCall A.L., Mullin C.J. : Home blood glucose monitoring: keystone for modern diabetes care.

    Bloedglucosebepaling, Jones P.M. : Use of a course on self-control behavior techniques to increase adherence to prescribed frequency for self-monitoring blood glucose.

    Wat is diabetes?, Type 1

    Bloedglucosebepaling, Ryan E.A., Miller J., Skyler J.S. : Finger sepsis: possible complication of self monitoring of blood glucose concentrations.

    Nieuws, Gel vervangt injecties

    Nieuws, Nieuwe ontdekking in het voorkomen van complicaties

    Wat is diabetes?, Zwangerschapsdiabetes

    BD, BD Logo en alle andere merknamen zijn - tenzij anders vermeld - eigendom van Becton, Dickinson and Company. © 2005 BD